3D+ aims to cover the absence of digital surgical planning and 3D printing services in the healthcare sector within the entire region, by utilizing its expertise and technology (Additive manufacturing & AI artificial intelligence) throughout surgery, Education, research and humanitarian.

Building up a screening & diagnostic program using big data & incremental AI approach to reach accurate detection & predication of the disease which designed to be accessible and affordable for both genders to improve quality of life, decrease community, social & economic burden of late diagnosis.

Contactless, non-intrusive alert device that automatically detects a patient that is in need of medical attention and alerts first responders immediately. The device is designed to detect abnormal behavior such as prolonged lack of activity or detect a fall or a patient laying on the ground and trigger an automatic alarm accordingly.

Our food security and agricultural biodiversity, are threatened due to tremendous losses of bee colonies worldwide during the last decade.
Beekeepers raise their beehives in the mountains and on farms. They can rarely fix problems at an early stage. For these reasons, we devolved the SmartBee device.
It can record and transmit the hives’ data to monitor the health and production of colonies.
Using the collected data and specific Genetic Breeding Value modelling, we can select colonies with the best genetic strains for better resiliency and productivity in their local environment.

Cambridge Nucleomics is solving major problems in RNA drug development by using a cutting-edge technology that combines DNA nanotechnology and nanopore sensing to analyse RNA target and drugs in a revolutionary way.

First Indonesia company operates fully integrated bioconversion from cassava genetic improvement, regenerative farming, value added processing, and waste recycling. Refer to ecological balance; we strive to prioritize the transformation process in every production line to maximize the value as well as zero-waste production.

Involving insect in bioconversion to produce sustainable protein source for animal feed and combined with cassava we are able to produce a low cost of fish and poultry

We are a prosthetic and splints manufacturer by 3d printing, we have the knowledge and the experience and the ability to make any type of splints or prosthetics for any case.

Digital Solution for measuring arterial stiffness

Glucose Biosensors provide innovative solutions to non-invasively measure and monitor Glucose level in the blood.

Green Desert is a biotechnology Saudi Arabian start-up company founded in January 2020. Green Desert aims to heal the ecological issues of Saudi Arabia and the gulf countries. GD's ultimate goal is to eliminate the vicious circle occurring in Saudi Arabia and the region. The company envisioned becoming the premier and preferred leading Cannabis sativa-based products provider in the MENA province.

"Haven Scientific is a local registered company specialized in designing and manufacturing molecular biology kits, such as DNA/RNA extraction kits and PCR assays (gene expression, genotyping, pathogen detection, etc.). Haven Scientific is the first of its kind in the Middle East and North Africa.".

We're rising to the clean Water, Sanitation and Hygiene (W.A.S.H) challenges across Sub Saharan Africa, the world's final frontier. Our solution is Electrochemical Activation Technology; this converts salt, water and an electro charge into a safe, potent and highly sustainable biocide. The result is broad spectrum impact in healthcare, agro, food processing and on demand water treatment. Humanity's greatest sanitation and hygiene challenges come from Africa - Hypoguard is creating a localised and high impact solution.

Cancer is the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Kinimmune is a clinical-stage biotechnology company discovering and developing quick-to-market intratumoral immunostimulants for unlocking the full potential of checkpoint inhibition in solid tumors. Kinimmune is the first Saudi American biotech company whose cancer therapy reached the clinical stages in the United States of America after obtaining the approval of the US Food and Drug Administration (FDA) to start the phase I clinical trial (NCT03982212). With extensive team experience in biotechnology between Saudi Arabia (King Abdulaziz University) and the United States (The University of Kansas), we’re working to harness the immune system's potential to fight cancer.

Logistics digital platform system that facilitate the request of the client in laboratory tests and services, throughout online request for the specific test and service. Labop will arrange the pick up and return the result back to the client with specific codes.

Manufacturing of cellular immunotherapies; chimeric antigen receptor (CAR) CAR-T cell therapies; as medicinal tools to fight against cancer.

Biodegradable and environmentally friendly surfactants to replace chemical surfactants used for cleaning detergents and surface tension reducing agents.

A local startup that invented a technology where we could take any cotton based textile, and apply our patented nano technology coating approach to that textile, which converts that textile into a textile that prevents microbial growth

Develop a gene editing therapeutic nanorobot for patients with Sickle Cell Disease. It relies on artificial intelligence-enabled lipid nanoparticles called �Nanopalm�, which is being trialed at the National Guard Hospital, Riyadh, to perform a single base editing to erase SCD in a safer, affordable, and more efficient route.

NoorDx is a biotechnology company focused on providing localized capacity and expertise to support and advance utilization of genomics‭ ‬in the healthcare and R&D sectors.

Novai is a British biotechnology start-up, developing DARC (Detection of Apoptosing Retinal Cells), an approved exploratory biomarker by FDA, MHRA and TGA for use in Age-related Macular Degeneration, Glaucoma and other clinical studies. DARC combines an innovative patented biologic with a state-of-the-art AI algorithm and uses standard imaging equipment to identify cellular level disease activity. Novai intends to bring DARC to market as a diagnostic and therapy prognosis, as a first indication, with opportunities for novel expansion of DARC as a targeted drug delivery vehicle which can overcome biological barriers known to impede drug delivery to eye and brain.

OPTIMA-Dx is building next-generation Point-Of-Care and At-home diagnostics for viral and bacterial pathogens and genetic disease markers to improve human health.
More than half of the population lacks access to timely and accurate diagnostics. And existing molecular diagnostics infrastructure is limited to reliable but centralized products or point-of-care but unreliable products.

We solve this diagnostic gap. Powered by our proprietary CRISPR biotechnologies, our OPTIMA-Dx platform makes accurate, sensitive, specific, user-friendly, and affordable diagnostics tests accessible to people at the point-of-care or at-home.

We are a diverse team of experts spinning out from KAUST, and our vision is to advance healthcare accessibility through decentralizing precision diagnostics.


OPTIMA-Dx makes diagnostics accessible to everyone everywhere to improve human health and the quality of life.

Plansulin intends to disrupt the insulin market by developing cheaper insulin from transgenic plants. Previous experiments have demonstrated the feasibility of using transgenic plants to manufacture recombinant insulin at commercial scale. Global Human Insulin Market is estimated to be US$ 40 Billion and growing at a 7.6% CAGR. The demand for insulin looks set to rise. Led by increasing incidence of the disease, and oral delivery. Pilot MVP product will be ready by Q1 2023. Full-scale batches will then be produced prior to clinical trial production leading to product registration and approval by 2025, 100% manufactured in Saudi Arabia.

Proteinea - a biotech company engineering proteins to tackle life-threatening diseases. The Artificial intelligence platform for biotherapeutics engineering along with the novel production process promises innovative therapeutic modalities accessible to everyone.

Local biotech company that provide high quality recombinant proteins and diagnostic kits for medical and research purposes in local and regional markets

Rubiks Omics is a next-generation sequencing startup company specializing in designing and running bespoke genetic tests to enable clinicians to choose the right treatment for patients of Arab ancestry. Our mission is to utilize genomics to develop IP-protected genomics tests, starting with cancer.
We leverage our genomic database obtained from patients from the Middle East and North Africa, and partner with major biotech companies like Illumina and world-class genomic facilities like UCL Genomics in England to establish our facility and rapid testing workflow.
We aim to change the lives of millions of Arab patients yearly through improved personalised care.

Sci-Insights AI is a bioinformatic SaaS company for research labs. Biologists use it to rapidly analyze and plot RNA-seq data, without the need to code in R or Python!

The landscape of genetic disease in Saudi Arabia specifically is known to be dominated by autosomal recessive disorders because of the highly consanguineous nature of this population. Additionally, it also has been shown that because of this population characteristic, there is a higher occurrence of recessive, typically homozygous, mutations causing genetic disease, we present a comprehensive approach for noninvasive prenatal screening applicable for autosomal recessive conditions (ShomoolTM), based on cffDNA next-generation sequencing.

AI + Biology for sustainable chemicals

SilicoLife designs optimized microorganisms and novel pathways for industrial biotechnology applications, based on artificial intelligence and synthetic biology approaches, shortening the development time and costs of new highly effective processes for the production of specific target compounds such as chemicals, food ingredients or biopolymers.

Currently, there are about 7500 genetic disorders, most of them are lethal and incurable. Gene editing is the main hope for the patients. However, gene editing tools have limitations. The Editing discovered a natural human protein that in coordination with CRISPR/cas system can produce precise DNA edits of up to 30 bp thus capable of treating 89% of all genetic disorders.

Fast, Low-cost, high-quality testing applications for camels.